We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Protein Identification Platform To Be Installed in China

By Labmedica staff writers
Posted on 31 Jan 2008
A software platform for the identification and characterization of proteins and peptides from mass spectrometry (MS) data is to be installed in China.

Called Phenyx, the platform was specifically designed to meet the demands of high-throughput MS data analysis and dynamic results assessment while providing a flexible user experience and adaptable architecture to instill confidence in results assessment.

Geneva Bioinformatics (GeneBio; Geneva, Switzerland) SA and the Chinese State Key Laboratory of Proteomics (Beijing, China) have announced an agreement that GeneBio's Phenyx protein identification platform will be installed on the Chinese State Key Laboratory of Proteomics' High Performance Computing Cluster (32 nodes).

The director of the Chinese State Key Laboratory of Proteomics, Prof. More...
Fuchu He, is also co-chair of the Human Proteome Organization's Human Liver Proteome Project (HUPO HLPP). The license agreement is a further link between GeneBio and numerous HUPO projects, including the Proteomics Standards Initiative and the HUPO Brain Proteome Project.

"We are very pleased to be working with GeneBio and the SIB [Swiss Institute of Bioinformatics] and believe Phenyx to be the right platform for our cluster,” said Prof. Yunping Zhu of the Chinese State Key Laboratory of Proteomics. "Our laboratory is keen to provide the best results possible to our community, and for this it was obvious that the addition of Phenyx's capabilities was mandatory. The quality of the identification results together with the suite of features the software provides, amongst which features the possibility to compare results from all major search engines, were very important factors in our decision.”

The Phenyx platform can be used for clinical applications if a diagnostic test needs mass spectrometry applications and an MS/MS-based peptide and protein identification tool. Therefore, if the instrument is used in a product ion scan mode (MS/MS), it will be able to infer or validate the presence of a given diagnostic peptide.

Geneva Bioinformatics (GeneBio) SA is a bioinformatics company providing the life science community with proteomics software that bridges the gap between information gathering and knowledge generation. Its expertise is focused on protein identification and characterization as well as proteome imaging, offering clients and partners the high degree of specialization essential to proteomics research.

The Chinese State Key Laboratory of Proteomics focuses on the basic application and research of proteomics. It is the only state key laboratory in the field of proteomics in China. Scientific interests include the proteome and functional network of key tissue/organ of human, proteomics study of key diseases, systems biology based on proteomics, and novel techniques of proteomics.


Related Links:
Geneva Bioinformatics

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.